EPHA2 and glioblastoma: To avoid the interference of PDGFRA on PDGFA-EPHA2 axis, we treated PDGFRA−/− GBM cells with PBS as control, recombinant soluble human EFNA1 with Fc-tag, and recombinant human PDGFA homodimer followed by RNA sequencing to profile transcriptomes (Dataset 10).